Protective effect of Lactobacillus plantarum 21, a probiotic on trinitrobenzenesulfonic acid-induced ulcerative colitis in rats

International Immunopharmacology

Volumn 25, Issue 2, 2015, Pages 504-510

  Satish Kumar, C S V ^a   Kondal Reddy, K ^a   Reddy, A Gopala ^a   Vinoth, A ^b   Ch, Sudha Rani Chowdary ^c   Boobalan, G ^a   Rao, G S ^c  

^a Uttar Pradesh Pandit Deen Dayal Upadhayay Pashu Chikitsa Vigyan Vishwavidyalay Evum Go Anusandhan Sansthan   (India)

^b PROJECT DIRECTORATE ON POULTRY   (India)

^c NTR College of Veterinary Science   (India)

Author keywords

Colitis; Cytokines; Free radicals; LAB 21; NO

Indexed keywords

GLUTATHIONE; INTERLEUKIN 10; INTERLEUKIN 1BETA; LIPID; MESSENGER RNA; NITRIC OXIDE; PROBIOTIC AGENT; SALAZOSULFAPYRIDINE; TRINITROBENZENESULFONIC ACID; TUMOR NECROSIS FACTOR ALPHA; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL COLITIS; EXPERIMENTAL INFLAMMATORY BOWEL DISEASE; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; LACTOBACILLUS PLANTARUM; LIPID PEROXIDATION; NONHUMAN; PRIORITY JOURNAL; PROTECTION; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE LEVEL; ULCERATIVE COLITIS; UPREGULATION; WESTERN BLOTTING; ANIMAL; CHEMICALLY INDUCED; COLON; DIET THERAPY; GENETICS; METABOLISM; PATHOLOGY; WISTAR RAT;

ANIMALS; COLITIS, ULCERATIVE; COLON; FEMALE; GLUTATHIONE; INTERLEUKIN-10; INTERLEUKIN-1BETA; LACTOBACILLUS PLANTARUM; NITRIC OXIDE; PROBIOTICS; RATS, WISTAR; RNA, MESSENGER; THIOBARBITURIC ACID REACTIVE SUBSTANCES; TRINITROBENZENESULFONIC ACID; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84924730808     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2015.02.026     Document Type: Article

References (29)

1. A. Kaser, S. Zeissig, and R.S. Blumberg Inflammatory bowel disease Annu Rev Immunol 28 2010 573 621
2. O. Palm, B. Moum, J. Jahnsen, and J.T. Gran The prevalence and incidence of peripheral arthritis in patients with inflammatory bowel disease, a prospective population-based study (the IBSEN study) Rheumatology 40 2001 1256 1261
3. R.J. Xavier, and D.K. Podolsky Unravelling the pathogenesis of inflammatory bowel disease Nature 448 2007 427 434
4. C. Bossone, J.M. Hosseini, V. Pineiro-Carrero, and T. Shea-Donohue Alterations in spontaneous contractions in vitro after repeated inflammation of rat distal colon Am J Physiol Gastrointest Liver Physiol 280 2001 949 957
5. B.B. Aggarwal Signalling pathways of the TNF superfamily: a double edged sword Nat Rev Immunol 3 2003 745 756
6. J.W. Larrick, and S.C. Wright Cytotoxic mechanism of tumor necrosis factor-α FASEB J 4 14 1990 3215 3223
7. H. Herfarth, U. Bocker, R. Janardhanam, and R.B. Sartor Subtherapeutic corticosteroids potentiate the ability of interleukin-10 to prevent chronic inflammation in rats Gastroenterology 115 1998 856 865
8. H. Kimura, S. Miura, T. Shigematsu, N. Ohkubo, Y. Tsuzuki, and I. Kurose, et al. Increased nitric oxide production and inducible nitric oxide synthase activity in colonic mucosa of patients with active ulcerative colitis and Crohn's disease Dig Dis Sci 42 1997 1047 1054
9. R. Joshi, S. Kumar, M. Unnikrishnan, and T. Mukherjee Free radical scavenging reactions of sulfasalazine, 5-aminosalicylic acid and sulfapyridine: mechanistic aspects and antioxidant activity Free Radic Res 39 11 2005 1163 1172
10. C. Campieri, M. Campieri, V. Bertuzzi, E. Swennen, D. Matteuzi, and S. Stefoni, et al. Reduction of oxaluria after an oral course of lactic acid bacteria at high concentration: clinical nephrology-epidemiology-clinical trials Kidney Int 60 2001 1097 1105
11. C. Vanderpool, F. Yan, and B. Polk Mechanisms of probiotic action: implications for therapeutic applications in inflammatory bowel disease Inflamm Bowel Dis 14 2008 1585 1596
12. H. Morita, F. He, T. Fuse, A.C. Ouwehand, A.C. Hashimoto, and M. Hosoda, et al. Cytokine production by the murine macrophage cell line J774.1 after to lactobacilli Biosci Biotechnol Biochem 66 2002 1963 1966
13. S. Menard, C. Candalh, J.C. Bambou, K. Terpend, N. Cerf-Bensussan, and M. Heyman Lactic acid bacteria secrete metabolites retaining anti-inflammatory properties after intestinal transport Gut 53 2004 821 828
14. O. Shibolet, F. Karmeli, R. Eliakim, E. Swennen, P. Brigidi, and P. Gionchetti, et al. Variable response to probiotics in two models of experimental colitis in rats Inflamm Bowel Dis 8 2002 399 406
15. G.P. Morris, P.L. Beck, M.S. Herridge, W.T. Depew, M.R. Szewczuk, and J.L. Wallace Hapten-induced model of chronic inflammation and ulceration in the rat colon Gastroenterology 96 3 1989 795 803
16. A.D. Millar, D.S. Rampton, C.L. Chander, A.W.D. Claxson, and D.R. Blake Evaluating the antioxidant potential of new treatments for inflammatory bowel disease in a rat model of colitis Gut 39 1996 407 415
17. M.A. Ellman Spectrophotometric method for determination of reduced glutathione in tissues Anal. Biochem. 74 1959 214 226
18. J.A. Buege, and S.D. Aust Microsomal lipid peroxidation methods Enzymologia 52 1978 302 310
19. K. Miranda, M.G. Espy, and D.A. Wink A rapid and simple spectrophotometric method for simultaneous detection of nitrate and nitrite Nitric Oxide 5 2001 62 71
20. K. Mousavizadeh, R. Rahimian, G. Fakhfouri, F.S. Aslani, and P. Ghafourifar Anti-inflammatory effects of 5-HT receptor antagonist, tropisetron on experimental colitis in rats Eur J Clin Invest 39 2009 375 383
21. L. Kruidenier, and H.W. Verspaget Review article: oxidative stress as a pathogenic factor in inflammatory bowel disease radicals or ridiculous? Aliment Pharmacol Ther 16 2002 1997 2015
22. L. Peran, D. Camuesco, M. Comalada, A. Nieto, A. Concha, and J.L. Adrio, et al. Lactobacillus fermentum, a probiotic capable to release glutathione, prevents colonic inflammation in the TNBS model of rat colitis Int J Colorectal Dis 21 2006 737 746
23. G. Dijkstra, H. Moshage, and P.L. Jansen Blockade of NF-kappaB activation and donation of nitric oxide: new treatment options in inflammatory bowel disease? Scand J Gastroenterol 236 2002 37 41
24. Y. Lu, and L.M. Wahl Oxidative stress augments the production of matrix metalloproteinase-1, cyclooxygenase-2, and prostaglandin E2 through enhancement of NF-kappa B activity in lipopolysaccharide-activated human primary monocytes J Immunol 175 2005 5423 5429
25. M.B. Grisham, and T. Yamada Neutrophils, nitrogen oxides, and inflammatory bowel disease Ann N Y Acad Sci 664 1992 103 115
26. B.C. Sydora, S.M. MacFarlane, M. Lupicki, A.L. Dmytrash, L.A. Dieleman, and R.N. Fedorak An imbalance in mucosal cytokine profile causes transient intestinal inflammation following an animal's first exposure to faecal bacteria and antigens Clin Exp Immunol 161 2010 187 196
27. P. Castro-Santos, A. Suarez, L. López-Rivas, L. Mozo, and C. Gutierrez TNF alpha and IL-10 gene polymorphisms in inflammatory bowel disease. Association of - 1082 AA low producer IL-10 genotype with steroid dependency Am J Gastroenterol 101 2006 1039 1047
28. Xiang Jing, Ying-Hao Lin, Li-Hong Bi, Ji-De Wang, and Yang Baiand Si-De Liu Effects of interleukin-4 or interleukin-10 gene therapy on trinitrobenzenesulfonic acid-induced murine colitis BMC Gastroenterol 13 2013 165
29. M. Seitz, P. Loetscher, B. Dewald, H. Towbin, C. Rordorf, and H. Gallati, et al. Methotrexate action in rheumatoid arthritis: stimulation of cytokine inhibitor and inhibition of chemokine production by peripheral blood mononuclear cells Br J Rheumatol 34 1995 602 609